About 6 results found for searched term "HIV-1 protease-IN-3" (0.14 seconds)
Cat.No. | Name | Target |
---|---|---|
M41183 | HIV-1 protease-IN-3 | Anti-infection |
HIV-1 protease-IN-3 is a potent inhibitor of HIV-1 protease (IC50=71 nM; EC50=0.86 μM). | ||
M1657 | Atazanavir Sulfate | HIV Protease |
BMS-232632, Reyataz, CGP-73547 | ||
Atazanavir sulfate (BMS-232632, Reyataz) is an azapeptide inhibitor of HIV-1 protease. Atazanavir sulfate is a substrate and inhibitor of CYP3A4, and an inhibitor and inducer of P-glycoprotein (P-gp). Atazanavir sulfate is also a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM. | ||
M27589 | TMC310911 | HIV Protease |
ASC-09 | ||
TMC310911 is a potent and orally active HIV type-1 (HIV-1) protease inhibitor with EC50 values ranged from 2.2 nM to 14.2 nM for wild-type HIV-1. TMC310911 has potent activity against a wide spectrum of recombinant HIV-1 isolates. TMC310911 has strong antiviral activity. | ||
M38764 | Indinavir | Anti-infection |
Indinavir (MK-639 free base) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir is also a SARS-CoV 3CLpro inhibitor. | ||
M41192 | HIV-1 protease-IN-8 | HIV Protease |
HIV-1 protease-IN-8 is a potent HIV-1 protease inhibitor with an IC50 value of 0.32 nM. | ||
M53461 | HIV-1 protease-IN-7 | HIV Protease |
HIV-1 protease-IN-7 is an orally active HIV-1 protease inhibitor (IC50=3.52 nM, EC50=37 nM). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.